Why TG Therapeutics Is Plunging More Than 40% Today

Shares of biopharma outfitTG Therapeutics (TGTX-2.90%)are down to the tune of 43.4% as of 11:38 a.m. ET Tuesday after the company announced the U.S. Food and … See more

40%
OFF

Why TG Therapeutics Is Plunging More Than 40% Today

2 weeks from now

Shares of biopharma outfitTG Therapeutics (TGTX-2.90%)are down to the tune of 43.4% as of 11:38 a.m. ET Tuesday after the company announced the U.S. Food and … See more

fool.com

$29.54
OFF

The TGTX Stock Mystery: Why Did TGTX Plunge Today?

2 weeks from now

Nov 16, 2024 · TG Therapeutics Inc common stock (TGTX) Stock Trading Recap. On Friday, TG Therapeutics Inc common stock (TGTX) stock saw a decline, ending the day at $29.54 which …

bovnews.com

82%
OFF

After Plunging -9.82% In 4 Weeks, Here's Why The Trend Might …

2 weeks from now

Apr 30, 2024 · TG Therapeutics (TGTX) has been on a downward spiral lately with significant selling pressure. After declining 9.8% over the past four weeks, the stock looks well positioned …

yahoo.com

82%
OFF

After Plunging -9.82% In 4 Weeks, Here's Why The Trend Might …

2 weeks from now

Apr 30, 2024 · Since 1988 it has more than doubled the S&P 500 with an average gain of +24.35% per year. These returns cover a period from January 1, 1988 through December 2, …

zacks.com

40%
OFF

Why TG Therapeutics Is Plunging More Than 40% Today - Sharewise

2 weeks from now

Nov 30, 2021 · Shares of biopharma outfit TG Therapeutics (NASDAQ: TGTX) are down to the tune of 43.4% as of 11:38 a.m. ET Tuesday after the company announced the U.S. Food and …

sharewise.com

40%
OFF

Why TG Therapeutics (TGTX) Stock Crashed 40% Today

2 weeks from now

Nov 30, 2021 · TG Therapeutics (NASDAQ: TGTX) stock price is down nearly 40% today after the company announced the U.S. Food and Drug Administration (FDA) plans to hold a meeting of …

streetinsider.com

4%
OFF

Why TG Therapeutics Stock Is Crashing Today - Yahoo

2 weeks from now

Aug 1, 2023 · Shares of TG Therapeutics (NASDAQ: TGTX) were crashing 50.4% lower as of 11:12 a.m. ET on Tuesday. Multiple sclerosis (MS) drug Briumvi, which launched in the U.S. in …

yahoo.com

60%
OFF

Why TG Therapeutics Stock Is Falling Today - Benzinga

2 weeks from now

Nov 30, 2021 · TGTX Price Action: TG Therapeutics has traded as high as $56.74 and as low as $21.05 over a 52-week period. The stock was down 41.60% at $13.65. TGTX TG …

benzinga.com

63%
OFF

Down -12.63% In 4 Weeks, Here's Why You Should You Buy The …

2 weeks from now

Jul 24, 2023 · TG Therapeutics (TGTX) has been beaten down lately with too much selling pressure. While the stock has lost 12.6% over the past four weeks, there is light at the end of …

yahoo.com

$32.84
OFF

Why Did TG Therapeutics Inc Common Stock (TGTX) Stock Plunge

2 weeks from now

Dec 10, 2024 · TG Therapeutics Inc common stock (TGTX) Stock Trading Recap. On Monday, TG Therapeutics Inc common stock (TGTX) stock saw a decline, ending the day at $32.84 …

bovnews.com

40%
OFF

What's Going On With TG Therapeutics Stock Today?

2 weeks from now

Aug 1, 2023 · TG Therapeutics Inc (NASDAQ:TGTX) shares are down over 40%. The company reported Q2 FY23 Briumvi net sales of $16 million in the U.S., with total net revenue of …

businessinsider.com

4%
OFF

TG Therapeutics Stock Crashes After Briumvi Misses 'Whisper ...

2 weeks from now

Nov 4, 2024 · On today's stock market, TG Therapeutics stock tumbled 9.4% to 24.36. ... Learn how you can make more money with IBD's investing tools, top-performing stock lists, and …

investors.com

$40
OFF

The Analyst Verdict: TG Therapeutics In The Eyes Of 5 Experts

2 weeks from now

Oct 29, 2024 · The 12-month price targets, analyzed by analysts, offer insights with an average target of $40.4, a high estimate of $50.00, and a low estimate of $20.00.

nasdaq.com

30%
OFF

TG Therapeutics Stock Just Rallied 30%: What Happened? - MSN

2 weeks from now

TG Therapeutics Inc (NASDAQ: TGTX) is up 30% on Wednesday even though it reported a wider-than-expected per-share loss for its fiscal first quarter. Why is TG Therapeutics stock up …

msn.com

$103
OFF

What's Going On With TG Therapeutics Stock Tuesday?

2 weeks from now

1 day ago · TG Therapeutics expects fourth-quarter BRIUMVI net product revenue in the U.S. to be $103.6 million. TG Therapeutics says it expects to report a 2024 year-end cash position of …

benzinga.com

$113
OFF

Why TG Therapeutics Stock Is Crushing It Today

2 weeks from now

Nov 1, 2023 · TG Therapeutics also generated net income of $113.9 million, or $0.73 per diluted share, compared to a net loss of $35.8 million, or $0.26 per share, in the third quarter of 2022. …

fool.com

7%
OFF

TG Therapeutics Shares Climb 7% As Sales Grow For ... - MarketWatch

2 weeks from now

Shares of TG Therapeutics rose after the company raised its guidance on better-than-expected sales of its multiple sclerosis drug. Shares were up 7.7% Tuesday to $29.79. The stock is …

marketwatch.com

$525
OFF

TG Therapeutics Stock Gains On Briumvi Sales (TGTX:NASDAQ)

2 weeks from now

1 day ago · According to TG Therapeutics (NASDAQ:TGTX), the intravenously delivered treatment is expected to generate about $525M in net product revenue this year from the U.S., …

seekingalpha.com

9%
OFF

Why TGTX Stock Is Rallying Today - MSN

2 weeks from now

The shares of drug maker TG Therapeutics (TGTX) are climbing 9% today after the firm preannounced higher-than-expected 2024 revenue from its multiple sclerosis drug, Briumvi. …

msn.com

$537
OFF

TG Therapeutics Stock Rises On Strong Q4 And Full-year Revenue

2 weeks from now

1 day ago · Market consensus for TG Therapeutics' 2025 revenue is slightly below the company's target at $537.8 million, indicating that the firm's guidance is in line with analyst expectations.

investing.com

FAQs about Why TG Therapeutics Is Plunging More Than 40% Today Coupon?

Why is TG Therapeutics stock up 30% on Wednesday?

TG Therapeutics Inc (NASDAQ: TGTX) is up 30% on Wednesday even though it reported a wider-than-expected per-share loss for its fiscal first quarter. Why is TG Therapeutics stock up today? The biotech stock is being rewarded primarily because the revenue printed at $63.47 million versus analysts at $54.61 million. ...

Why did TG Therapeutics stock rise?

By Owen Tucker-Smith Shares of TG Therapeutics rose after the company raised its guidance on better-than-expected sales of its multiple sclerosis drug. Shares were up 7.7% Tuesday to $29.79. The stock is about 18% below its 52-week high of $36.84. ...

Should you buy TG Therapeutics (tgtx)?

TG Therapeutics (TGTX) has been beaten down lately with too much selling pressure. While the stock has lost 12.6% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnings than they predicted earlier. ...

Why are TG Therapeutics (tgtx) shares climbing 9% today?

The shares of drug maker TG Therapeutics (TGTX) are climbing 9% today after the firm preannounced higher-than-expected 2024 revenue from its multiple sclerosis drug, Briumvi. Briumvi's 2024 Revenue Exceeded TG's Guidance The company estimated today that its 2024 revenue from the MS treatment had come in at $310 million. ...

Is TG Therapeutics stock down 15% versus its year-to-date high?

TG Therapeutics stock is still down 15% versus its year-to-date high. Note that TG Therapeutics lost 7 cents a share in its first financial quarter which was worse than 4 cents a share that experts had forecast. ...

Does the Motley Fool recommend TG Therapeutics?

The Motley Fool recommends TG Therapeutics. The Motley Fool has a disclosure policy. The biopharmaceutical company's Q3 update was music to investors' ears. ...